Total Visits

Views
Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A64

Select a period of time:

Views

Views
May 20251
June 20251
July 202519
August 20250
September 20251
October 20250
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
United States6
United Kingdom3
Guatemala1
Mexico1
Senegal1
South Africa1
 

Top cities views

Views
São Paulo4
Campinas1
Dakar1
Decatur1
Euclid1
Great Bend1
Guatemala City1
Houston1
Johannesburg1
Johns Island1